HPV testing is an efficient management choice for women with inadequate liquid-based cytology in cervical cancer screening.
暂无分享,去创建一个
M. Zorzi | G. Collina | A. Del Mistro | P. Dalla Palma | A. Gillio-Tos | G. Ronco | N. Segnan | P. Giorgi Rossi | M. Confortini | M. L. Schiboni | B. Ghiringhello | F. Carozzi | A. Pellegrini | M. De Lillo | P. Maioli | L. Zaffina | Anna Gillio-Tos
[1] C. Magnani,et al. [Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)]. , 2012, Epidemiologia & Prevenzione.
[2] Gabriella Guasticchi,et al. Distribution of high and low risk HPV types by cytological status: a population based study from Italy , 2011, Infectious Agents and Cancer.
[3] M. Desai,et al. Accuracy of liquid‐based cytology , 2010, Cancer cytopathology.
[4] G. Ronco,et al. Age‐specific patterns of unsatisfactory results for conventional Pap smears and liquid‐based cytology: data from two randomised clinical trials , 2010, BJOG : an international journal of obstetrics and gynaecology.
[5] S. Ciatto,et al. Risk of CIN2 in Women With a Pap Test Without Endocervical Cells vs. Those With a Negative Pap Test With Endocervical Cells , 2010, Acta Cytologica.
[6] J. Cuzick,et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. , 2010, The Lancet. Oncology.
[7] J. Peto,et al. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening. , 2009, Health technology assessment.
[8] C. Clar,et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. , 2009, Health technology assessment.
[9] P. Sparén,et al. Process performance of cervical screening programmes in Europe. , 2009, European journal of cancer.
[10] G. Collina,et al. The reproducibility of CIN diagnoses among different pathologists: data from histology reviews from a multicenter randomized study. , 2009, American journal of clinical pathology.
[11] P Barton,et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. , 2009, Health technology assessment.
[12] Chengquan Zhao,et al. High-Risk Human Papillomavirus DNA Test Results Are Useful for Disease Risk Stratification in Women With Unsatisfactory Liquid-Based Cytology Pap Test Results , 2009, Journal of lower genital tract disease.
[13] L. Irwig,et al. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice. , 2008, Patient education and counseling.
[14] Chengquan Zhao,et al. Adjunctive high‐risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample , 2008, Cancer.
[15] J. Cuzick,et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. , 2008, Journal of the National Cancer Institute.
[16] Marc Arbyn,et al. Liquid Compared With Conventional Cervical Cytology: A Systematic Review and Meta-analysis , 2008, Obstetrics and gynecology.
[17] Chengquan Zhao,et al. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone. , 2007, Gynecologic oncology.
[18] A. Bondi,et al. Interlaboratory reproducibility of liquid‐based equivocal cervical cytology within a randomized controlled trial framework , 2007, Diagnostic cytopathology.
[19] J. Cuzick,et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial , 2007, BMJ : British Medical Journal.
[20] M. Zorzi,et al. Extension of organised cervical cancer screening programmes in Italy and their process indicators. , 2007, Epidemiologia e prevenzione.
[21] J. Cuzick,et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. , 2007, European journal of cancer.
[22] J. Cuzick,et al. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. , 2006, The Lancet. Oncology.
[23] J. Cuzick,et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. , 2006, Journal of the National Cancer Institute.
[24] W. Lawrence,et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). , 2006, Journal of the National Cancer Institute.
[25] A. Tos,et al. Reproducibility of HPV DNA Testing by Hybrid Capture 2 in a Screening Setting. , 2005, American journal of clinical pathology.
[26] Allan M. Seidenfeld,et al. Results of the implementation of liquid‐based cytology—SurePath in the Ontario screening program , 2004, Cancer.
[27] Joan L. Walker. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. , 2003, American journal of obstetrics and gynecology.
[28] J. T. Cox,et al. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). , 2002, Journal of the National Cancer Institute.
[29] C. De Marco,et al. [Smoking in car: monitoring pollution of particulate matter, of organic volatile compounds and of carbon monoxide. The effect of opening the driver's window]. , 2010, Epidemiologia e prevenzione.
[30] M. Bibbo,et al. The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. , 1992, The Journal of reproductive medicine.